The duty to disclose adverse clinical trial results.
Participants in some clinical trials are at risk of being harmed and sometimes are seriously harmed as a result of not being provided with available, relevant risk information. We argue that this situation is unacceptable and that there is a moral duty to disclose all adverse clinical trial results...
Автори: | Liao, S, Sheehan, M, Clarke, S |
---|---|
Формат: | Journal article |
Мова: | English |
Опубліковано: |
2009
|
Схожі ресурси
Схожі ресурси
-
Disclosing clinical trial results: publicity, significance and independence.
за авторством: Liao, S, та інші
Опубліковано: (2009) -
Randomization should be disclosed to potential research subjects.
за авторством: Binik, A, та інші
Опубліковано: (2013) -
Comparative Study of Securities issuer's affirmative duty to disclose information
in Iranian and American Law
за авторством: Morteza Shahidi, та інші
Опубліковано: (2020-04-01) -
Press releases for Phase 2 clinical trial topline results: Have the objective pre-specified efficacy results been disclosed?
за авторством: Zheng Su, та інші
Опубліковано: (2016-12-01) -
HIV/AIDS, TO DISCLOSE OR NOT TO DISCLOSE: THAT IS THE QUESTION
за авторством: Andra le Roux-Kemp
Опубліковано: (2013-04-01)